According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the...
from NDTV News - World-news https://ift.tt/VXcjuWv
from NDTV News - World-news https://ift.tt/VXcjuWv
World
![World]()
Reviewed by Latest trending news
on
February 06, 2022
Rating:
No comments:
Note: only a member of this blog may post a comment.